MRKR Message Board Post 17841838 | Marker Therapeutics Inc.
home / stock / mrkr / mrkr message board
hermanboren
(investorshub)
Posted on: Jun/23/2023 15:21:08
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172197507
Good point & very true. Thanks
News, Short Squeeze, Breakout and More Instantly...
-
Preliminary safety and efficacy with sustained objective responses observed in patients with lymphoma treated with MT-601 in Phase 1 APOLLO study Study participant with Non-Hodgkin’s Lymphoma who relapsed within 90 days of anti-CD19 CAR T cell therapy remains in complete response...
-
Preliminary data from study in patients with lymphoma enrolled at City of Hope National Medical Center was presented at the 11 th Global Summit on Hematologic Malignancies in Whistler, BC, Canada Study participants tolerated initial dose level well and demonstrated durab...